Research on the role of Nrf2 in human renal cell carcinoma (RCC) has been mainly focused on papillary type 2 RCC (pRCC2), since an aggressive form of this tumor is characterized by increased oxidative stress and activation of the Nrf2-ARE pathway [14, 15]. The gene discussed is NFE2L2; the disease is neoplasm.